These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling]. Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542 [TBL] [Abstract][Full Text] [Related]
4. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Spinale FG; Coker ML; Thomas CV; Walker JD; Mukherjee R; Hebbar L Circ Res; 1998 Mar; 82(4):482-95. PubMed ID: 9506709 [TBL] [Abstract][Full Text] [Related]
6. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Bradham WS; Moe G; Wendt KA; Scott AA; Konig A; Romanova M; Naik G; Spinale FG Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1288-95. PubMed ID: 11893563 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Spinale FG Circ Res; 2002 Mar; 90(5):520-30. PubMed ID: 11909815 [TBL] [Abstract][Full Text] [Related]
8. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Spinale FG; Coker ML; Bond BR; Zellner JL Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226 [TBL] [Abstract][Full Text] [Related]
9. Myocardial extracellular matrix remodeling with the development of pacing induced congestive heart failure contributory mechanisms. Coker ML; Spinale FG Cardiovasc Pathol; 1998; 7(3):161-8. PubMed ID: 25851223 [TBL] [Abstract][Full Text] [Related]
10. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function. Spinale FG; Coker ML; Krombach SR; Mukherjee R; Hallak H; Houck WV; Clair MJ; Kribbs SB; Johnson LL; Peterson JT; Zile MR Circ Res; 1999 Aug; 85(4):364-76. PubMed ID: 10455065 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix remodeling following myocardial injury. Lindsey ML; Mann DL; Entman ML; Spinale FG Ann Med; 2003; 35(5):316-26. PubMed ID: 12952018 [TBL] [Abstract][Full Text] [Related]
13. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Coker ML; Thomas CV; Clair MJ; Hendrick JW; Krombach RS; Galis ZS; Spinale FG Am J Physiol; 1998 May; 274(5):H1516-23. PubMed ID: 9612358 [TBL] [Abstract][Full Text] [Related]
14. MMP induction and inhibition in myocardial infarction. Lindsey ML Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764 [TBL] [Abstract][Full Text] [Related]
15. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092 [TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair. Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169 [TBL] [Abstract][Full Text] [Related]
17. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure. Song YH; Li BS; Chen XM; Cai H Int J Mol Med; 2008 Jan; 21(1):117-24. PubMed ID: 18097624 [TBL] [Abstract][Full Text] [Related]
18. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Nishikawa N; Yamamoto K; Sakata Y; Mano T; Yoshida J; Miwa T; Takeda H; Hori M; Masuyama T Cardiovasc Res; 2003 Mar; 57(3):766-74. PubMed ID: 12618238 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176 [TBL] [Abstract][Full Text] [Related]
20. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Bozkurt B; Kribbs SB; Clubb FJ; Michael LH; Didenko VV; Hornsby PJ; Seta Y; Oral H; Spinale FG; Mann DL Circulation; 1998 Apr; 97(14):1382-91. PubMed ID: 9577950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]